Glenmede Trust’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-3,908
| Closed | -$311K | – | 1335 |
|
|
2021
Q1 | $311K | Sell |
3,908
-279,763
| -99% | -$21.8M | ﹤0.01% | 967 |
|
|
2020
Q4 | $22.4M | Buy |
283,671
+49,225
| +21% | +$2.89M | 0.12% | 199 |
|
|
2020
Q3 | $10.3M | Sell |
234,446
-35,400
| -13% | -$1.74M | 0.06% | 300 |
|
|
2020
Q2 | $11.9M | Sell |
269,846
-53,006
| -16% | -$1.98M | 0.07% | 283 |
|
|
2020
Q1 | $22.9M | Hold |
322,852
| – | – | 0.1% | 261 |
|
|
2019
Q4 | $22.9M | Sell |
322,852
-43,745
| -12% | -$3.17M | 0.1% | 261 |
|
|
2019
Q3 | $27.4K | Buy |
366,597
+632
| +0.2% | +$53.6K | 0.13% | 221 |
|
|
2019
Q2 | $29.5K | Buy |
365,965
+365,120
| +43,209% | +$25.7M | 0.13% | 223 |
|
|
2019
Q1 | $56 | Hold |
845
| – | – | ﹤0.01% | 1637 |
|
|
2018
Q4 | $62 | Buy |
845
+149
| +21% | +$12.3K | ﹤0.01% | 1505 |
|
|
2018
Q3 | $64K | Buy |
696
+70
| +11% | +$6.67K | ﹤0.01% | 1314 |
|
|
2018
Q2 | $62K | Hold |
626
| – | – | ﹤0.01% | 1381 |
|
|
2018
Q1 | $64K | Hold |
626
| – | – | ﹤0.01% | 1536 |
|
|
2017
Q4 | $64K | Sell |
626
-152
| -20% | -$15.1K | ﹤0.01% | 1536 |
|
|
2017
Q3 | $73K | Sell |
778
-72
| -8% | -$5.68K | ﹤0.01% | 1505 |
|
|
2017
Q2 | $68K | Hold |
850
| – | – | ﹤0.01% | 1492 |
|
|
2017
Q1 | $68K | Hold |
850
| – | – | ﹤0.01% | 1492 |
|
|
2016
Q4 | $66K | Hold |
850
| – | – | ﹤0.01% | 1525 |
|
|
2016
Q3 | $66K | Hold |
850
| – | – | ﹤0.01% | 1519 |
|
|
2016
Q2 | $58K | Hold |
850
| – | – | ﹤0.01% | 1528 |
|
|
2016
Q1 | $60K | Sell |
850
-200
| -19% | -$12.6K | ﹤0.01% | 1468 |
|
|
2015
Q4 | $65K | Sell |
1,050
-175
| -14% | -$10.7K | ﹤0.01% | 1485 |
|
|
2015
Q3 | $69K | Hold |
1,225
| – | – | ﹤0.01% | 1492 |
|
|
2015
Q2 | $65K | Hold |
1,225
| – | – | ﹤0.01% | 1543 |
|
|
2015
Q1 | $58K | Hold |
1,225
| – | – | ﹤0.01% | 1631 |
|
|
2014
Q4 | $52K | Sell |
1,225
-61
| -5% | -$2.49K | ﹤0.01% | 1739 |
|
|
2014
Q3 | $44K | Buy |
1,286
+1
| +0.1% | +$35 | ﹤0.01% | 1738 |
|
|
2014
Q2 | $47K | Buy |
1,285
+435
| +51% | +$14.8K | ﹤0.01% | 1639 |
|
|
2014
Q1 | $28K | Buy |
+850
| New | +$28K | ﹤0.01% | 1811 |
|
Glenmede Trust's CMD Position: Q2 2021 in Review
Glenmede Trust sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 3,908 shares — an estimated $311K sold.
Glenmede Trust first reported a position in CMD in Q1 2014 and held it in 29 quarters. The position peaked at $22.9M in Q1 2020. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Glenmede Trust reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Glenmede Trust sold 3,908 Cantel Medical Corporation shares in Q2 2021, an estimated $311K.
- Glenmede Trust first reported a position in Cantel Medical Corporation in Q1 2014 and held it in 29 quarters.
- Glenmede Trust's Cantel Medical Corporation position peaked at $22.9M in Q1 2020.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Glenmede Trust's 13F filing for Q2 2021, filed 16 Aug 2021.